BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28283362)

  • 21. Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation.
    Frangieh AH; Gruner C; Mikulicic F; Attinger-Toller A; Tanner FC; Taramasso M; Corti R; Grünenfelder J; Lüsche TF; Ruschitzka F; Bettex D; Maisano F; Gaemperli O
    EuroIntervention; 2016 Apr; 11(14):e1680-6. PubMed ID: 27056128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry.
    Puls M; Lubos E; Boekstegers P; von Bardeleben RS; Ouarrak T; Butter C; Zuern CS; Bekeredjian R; Sievert H; Nickenig G; Eggebrecht H; Senges J; Schillinger W
    Eur Heart J; 2016 Feb; 37(8):703-12. PubMed ID: 26614824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry.
    Scandura S; Capranzano P; Caggegi A; Grasso C; Ronsivalle G; Mangiafico S; Ohno Y; Attizzani GF; Cannata S; Giaquinta S; Farruggio S; Ministeri M; Dipasqua F; Pistritto AM; Immè S; Capodanno D; Di Salvo ME; Tamburino C
    Int J Cardiol; 2016 Dec; 224():440-446. PubMed ID: 27710781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous mitral valve repair with the MitraClip system according to the predicted risk by the logistic EuroSCORE: preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry.
    Wiebe J; Franke J; Lubos E; Boekstegers P; Schillinger W; Ouarrak T; May AE; Eggebrecht H; Kuck KH; Baldus S; Senges J; Sievert H;
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):591-8. PubMed ID: 24664460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study.
    Whitlow PL; Feldman T; Pedersen WR; Lim DS; Kipperman R; Smalling R; Bajwa T; Herrmann HC; Lasala J; Maddux JT; Tuzcu M; Kapadia S; Trento A; Siegel RJ; Foster E; Glower D; Mauri L; Kar S;
    J Am Coll Cardiol; 2012 Jan; 59(2):130-9. PubMed ID: 22222076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.
    Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W
    PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study.
    Glower DD; Kar S; Trento A; Lim DS; Bajwa T; Quesada R; Whitlow PL; Rinaldi MJ; Grayburn P; Mack MJ; Mauri L; McCarthy PM; Feldman T
    J Am Coll Cardiol; 2014 Jul; 64(2):172-81. PubMed ID: 25011722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.
    Triantafyllis AS; Kortlandt F; Bakker AL; Swaans MJ; Eefting FD; van der Heyden JA; Post MC; Rensing BW
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):467-75. PubMed ID: 26268819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: mid-term results of a single-centre experience†.
    De Bonis M; Taramasso M; Lapenna E; Denti P; La Canna G; Buzzatti N; Pappalardo F; Di Giannuario G; Cioni M; Giacomini A; Alfieri O
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):255-62. PubMed ID: 25669650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Coronary Artery Disease on Outcomes in Patients Undergoing Percutaneous Edge-to-Edge Repair.
    Shamekhi J; Weber M; Sugiura A; Öztürk C; Treede H; Grube E; Werner N; Nickenig G; Sinning JM
    JACC Cardiovasc Interv; 2020 Sep; 13(18):2137-2145. PubMed ID: 32972576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and predictors of early discharge after percutaneous edge-to-edge mitral valve repair.
    Tamburino C; Buccheri S; Popolo Rubbio A; Scandura S; Di Salvo ME; Mangiafico S; Immé S; Caruso G; Scalia M; Condorelli A; Barbanti M; Capranzano P; Capodanno D; Grasso C
    Heart; 2017 Jun; 103(12):931-936. PubMed ID: 28069638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and Midterm Outcome After MitraClip Therapy in Patients With Severe Mitral Regurgitation and Left Ventricular Dysfunction.
    Lesevic H; Sonne C; Braun D; Orban M; Pache J; Kastrati A; Schömig A; Mehilli J; Barthel P; Ott I; Sack G; Massberg S; Hausleiter J
    Am J Cardiol; 2015 Sep; 116(5):749-56. PubMed ID: 26160468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.
    Maisano F; Franzen O; Baldus S; Schäfer U; Hausleiter J; Butter C; Ussia GP; Sievert H; Richardt G; Widder JD; Moccetti T; Schillinger W
    J Am Coll Cardiol; 2013 Sep; 62(12):1052-1061. PubMed ID: 23747789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical revision after percutaneous mitral repair with the MitraClip device.
    Argenziano M; Skipper E; Heimansohn D; Letsou GV; Woo YJ; Kron I; Alexander J; Cleveland J; Kong B; Davidson M; Vassiliades T; Krieger K; Sako E; Tibi P; Galloway A; Foster E; Feldman T; Glower D;
    Ann Thorac Surg; 2010 Jan; 89(1):72-80; discussion p 80. PubMed ID: 20103209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.
    Feldman T; Kar S; Elmariah S; Smart SC; Trento A; Siegel RJ; Apruzzese P; Fail P; Rinaldi MJ; Smalling RW; Hermiller JB; Heimansohn D; Gray WA; Grayburn PA; Mack MJ; Lim DS; Ailawadi G; Herrmann HC; Acker MA; Silvestry FE; Foster E; Wang A; Glower DD; Mauri L;
    J Am Coll Cardiol; 2015 Dec; 66(25):2844-2854. PubMed ID: 26718672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.
    Lim DS; Reynolds MR; Feldman T; Kar S; Herrmann HC; Wang A; Whitlow PL; Gray WA; Grayburn P; Mack MJ; Glower DD
    J Am Coll Cardiol; 2014 Jul; 64(2):182-92. PubMed ID: 24184254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitral valve surgery in 6 patients after failed MitraClip therapy.
    Monsefi N; Zierer A; Khalil M; Ay M; Beiras-Fernandez A; Moritz A; Stock UA
    Tex Heart Inst J; 2014 Dec; 41(6):609-12. PubMed ID: 25593525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-do MitraClip in patients with functional mitral valve regurgitation and advanced heart failure.
    Kreusser MM; Weber A; Geis NA; Grossekettler L; Volz MJ; Hamed S; Katus HA; Pleger ST; Frey N; Raake PW
    ESC Heart Fail; 2021 Dec; 8(6):4617-4625. PubMed ID: 34498422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of residual mitral regurgitation after MitraClip implantation.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Int J Cardiol; 2017 Jan; 227():813-819. PubMed ID: 27823895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience.
    Adamo M; Curello S; Chiari E; Fiorina C; Chizzola G; Magatelli M; Locantore E; Cuminetti G; Lombardi C; Manzato A; Metra M; Ettori F
    Int J Cardiol; 2017 May; 234():53-57. PubMed ID: 28258847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.